Explore opportunities in Chinese vaccine market despite challenges
The CEO of CanSino Biologics, Xiu Feng Yu, emphasized the company's resilience in facing economic challenges and declining birth rates in China. He noted that the increasing elderly population presents a significant opportunity for growth in the vaccine market, supported by encouraging government policies.